HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Christos Prokakis Efstratios Koletsis Efstratios Apostolakis Nikolaos Baltayiannis Dimitrios Dougenis Permission Requests Citing Articles Citing Articles via HighWire Google Scholar Articles by Prokakis, C. Articles by Dougenis, D. PubMed Articles by Prokakis, C. Articles by Dougenis, D. Related Collections Mediastinum Related Article

---

Original Articles: General Thoracic

Modified Maximal Thymectomy for Myasthenia Gravis: Effect of Maximal Resection on Late Neurologic Outcome and Predictors of Disease Remission

^a Cardiothoracic Surgery Department, School of Medicine, Patras University, Patras, Greece
^b Department of Neurology, School of Medicine, Patras University, Patras, Greece
^c Department of Thoracic Surgery, Metaxa Hospital, Piraeus, Greece

Accepted for publication July 23, 2009.

^_* Address correspondence to Dr Koletsis, 31 Chlois St, Voula, Athens, 16673, Greece (Email: ekoletsis{at}hotmail.com).

Background: Although thymectomy is a standard practice of care in patients with myasthenia gravis, the best approach to thymic resection remains controversial. This study was conducted to assess the effect of maximal resection on neurologic outcome and identify predictors of disease remission.

Methods: Data of 78 myasthenic patients who underwent modified maximal thymectomy during a 17-year period were retrospectively analyzed. The primary study end point was the achievement of complete remission. Separate analysis was performed for thymoma and nonthymoma patients regarding the factors predicting the neurologic outcome.

Results: No patients died perioperatively. Surgical morbidity was 7.7%. The rate of postoperative myasthenic crisis was 3.8%. Thymoma and nonthymoma patients experienced comparable complete stable remission prediction (74.5% vs 85.7% at 15 years; p = 0.632). The absence of steroids in the preoperative medical treatment was statistically related to the prediction for complete stable remission in both thymoma (95% confidence interval [CI], 2.687 to 339.182, p = 0.006) and nonthymoma patients (95% CI, 1.607 to 19.183; p = 0.007) in multivariate analysis. In thymomatous myasthenia gravis, there was a statistically significant association between disease remission and the World Health Organization (WHO) histologic classification (95% CI, 0.262 to 0.827; p = 0.009).

Conclusions: Maximal resections are recommended in myasthenic patients. Disease severity represents the prime determinant of the neurologic outcome after thymectomy. The neurologic outcome in patients after thymectomy may be statistically associated with the WHO classification subtypes but not necessarily with the aggressiveness of these tumors.

Related Article

Invited Commentary

Cameron Wright
Ann. Thorac. Surg. 2009 88: 1646. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				C. Wright Invited commentary. Ann. Thorac. Surg., November 1, 2009; 88(5): 1646 - 1646. [Full Text] [PDF]